CClinicalTrials.gg
CompletedNCT06879990Updated Mar 19, 2025

Retrograde Saline Irrigation During Supine Mini Percutaneous Nephrolithotomy

An interventional study of Retrograde normal saline irrigation and Without Retrograde normal saline irrigation in Renal Stone and Supine Mini Percutaneous Nephrolithotomy, sponsored by Kafrelsheikh University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-19.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jan 2024, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This minimally invasive surgery allows us to remove kidney stones through tiny incisions and provides patients with quicker and smoother recoveries

02

Conditions studied

  • Renal Stone
  • Supine Mini Percutaneous Nephrolithotomy

Keywords

  • Supine
03

In context

Kidney Calculi

598 studies on the registry are indexed under Kidney Calculi; 163 are open to participants now.

This study's enrollment of 200 is above the median of 90 across 461 interventional studies indexed under Kidney Calculi.

Browse Kidney Calculi studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 285 studies on the registry; 110 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age above 18 years
  • renal stones

Exclusion criteria

Exclusion Criteria:

  • age less than 18 years
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    Supine mini percutaneous nephrolithotomy with irrigation

    Behavioral: Retrograde normal saline irrigation

  • Experimental
    Supine mini percutaneous nephrolithotomy without irrigation

    Behavioral: Without Retrograde normal saline irrigation

Interventions

  • BehavioralRetrograde normal saline irrigation

    Retrograde normal saline irrigation during supine Mini percutaneous nephrolithotomy

  • BehavioralWithout Retrograde normal saline irrigation

    Without Retrograde normal saline irrigation during supine Mini percutaneous nephrolithotomy

06

What researchers measure

Primary outcomes

  1. Stone free rate

    No stone residual fragments

    Time frame: two weeks from primary procedure

Secondary outcomes

  1. Assess operative time

    Assess operative time in minutes

    Time frame: During procedure

  2. Post operative complication

    Complication may occur post operative like fever , sever pain

    Time frame: Up to 48 hours

07

Study locations

1 site
  • Elsayed Abdelhalim
    Kafr Ash Shaykh, State 44749, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06879990
Lead sponsor
Kafrelsheikh University
Responsible party
Elsayed Abdelhalim Elsayed (assistant lecturer, urology department, Kafrelsheikh university,Msc, Kafrelsheikh University) — Principal investigator
First posted
Mar 17, 2025
Start date
Jan 1, 2024
Primary completion
Dec 31, 2024
Completion
Dec 31, 2024
Last update
Mar 19, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion